Unlocking the Secrets of Severe Asthma: Discover the Distinct Phenotypes Behind Multimorbidity for a Healthier Tomorrow
A recent study has unveiled distinct patterns of multimorbidity in patients with severe asthma across Europe, significantly enhancing our understanding of how related health issues cluster and impact disease severity and management. Severe asthma is characterized by persistent symptoms, frequent flare-ups, and diminished lung function, often exacerbated by multiple coexisting conditions that complicate treatment.
In an extensive analysis involving 2,690 patients from 11 countries, researchers explored the prevalence and combinations of comorbidities in those suffering from severe asthma. Their findings indicate that multimorbidity is not merely incidental; rather, it follows recognizable and reproducible patterns across various European regions, suggesting specific underlying clinical phenotypes associated with severe asthma.
The study identified three distinct comorbidity clusters that were consistent across all examined regions. The first cluster linked osteoporosis with steroid-induced weight gain, shedding light on the long-term impacts of corticosteroid use in asthma management. The second cluster included eczema and allergic rhinitis, reflecting an allergic or atopic profile commonly seen in these patients. The third cluster paired chronic sinusitis with nasal polyps, hinting at a robust connection between upper airway diseases and severe asthma.
Additional conditions such as obesity, bronchiectasis, gastro-esophageal reflux disease, and various psychological factors demonstrated more variable clustering patterns, emphasizing the diverse presentations of severe asthma. By grouping patients into multimorbidity phenotypes based on these clusters, researchers found significant correlations with clinical outcomes. Most notably, one prevalent phenotype featured sinonasal disease without a strong alignment to other conditions, while another large cohort showed no clear clustering pattern.
Crucially, the study highlighted a specific “steroid-associated multimorbidity phenotype,” which was linked to the worst clinical outcomes. Patients in this group exhibited higher reliance on maintenance oral corticosteroids, worse lung function, reduced asthma control, and more frequent exacerbations. Another group termed “maximal multimorbidity” presented with a significant comorbidity burden and an increased need for biologic therapies.
These findings underscore the necessity for clinicians managing severe asthma to recognize multimorbidity patterns rather than treating coexisting conditions in isolation. Patients exhibiting steroid-associated multimorbidity may benefit from early consideration of steroid-sparing strategies and closer surveillance for potential systemic complications.
This research advocates for a holistic approach to severe asthma, one that takes into account the clustering of comorbidities. Such an approach could lead to more personalized treatment strategies and ultimately enhance long-term health outcomes for patients.
In summary, this study encourages healthcare professionals to think of severe asthma as a multifaceted disease involving a complex array of comorbidities. By understanding these distinct multimorbidity patterns, clinicians can tailor treatment strategies to better address the unique needs of each patient.
Reference: Freeman A et al. Multimorbidity phenotypes and associated characteristics in severe asthma: an observational study of European severe asthma registries. Lancet Reg Health Eur. 2026;63:101600.
Tags: severe asthma, multimorbidity, healthcare, respiratory diseases, patient management
Original Source: https://www.emjreviews.com/respiratory/news/severe-asthma-multimorbidity-reveals-distinct-clinical-phenotypes/
Category :
Tags:
Publish Date: 2026-04-13 20:31:00
